These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37899546)

  • 1. Mapping the Lipid Signatures in COVID-19 Infection: Diagnostic and Therapeutic Solutions.
    Dasgupta A; Gangai S; Narayan R; Kapoor S
    J Med Chem; 2023 Nov; 66(21):14411-14433. PubMed ID: 37899546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
    Policard M; Jain S; Rego S; Dakshanamurthy S
    Virus Res; 2021 Aug; 301():198464. PubMed ID: 34058265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 pandemics: An update of CRISPR in diagnosis and host-virus interaction studies.
    Tang WF; Tran AT; Wang LY; Horng JT
    Biomed J; 2023 Apr; 46(2):100587. PubMed ID: 36849044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting lipid metabolism alterations in SARS-CoV-2.
    Casari I; Manfredi M; Metharom P; Falasca M
    Prog Lipid Res; 2021 Apr; 82():101092. PubMed ID: 33571544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis.
    Maleknia S; Tavassolifar MJ; Mottaghitalab F; Zali MR; Meyfour A
    Mol Med; 2022 Aug; 28(1):86. PubMed ID: 35922752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies.
    Zabidi NZ; Liew HL; Farouk IA; Puniyamurti A; Yip AJW; Wijesinghe VN; Low ZY; Tang JW; Chow VTK; Lal SK
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-based therapies against SARS-CoV-2 infection.
    Alketbi EH; Hamdy R; El-Kabalawy A; Juric V; Pignitter M; A Mosa K; Almehdi AM; El-Keblawy AA; Soliman SSM
    Rev Med Virol; 2021 Sep; 31(5):1-13. PubMed ID: 34546604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Viral Diagnostic Technologies for Combating COVID-19 and Future Pandemics.
    Zhu N; Wong PK
    SLAS Technol; 2020 Dec; 25(6):513-521. PubMed ID: 32833548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnologies for the Diagnosis and Treatment of SARS-CoV-2 and Its Variants.
    Park E; Choi SY; Kim J; Hildebrandt N; Lee JS; Nam JM
    Small Methods; 2023 Jul; 7(7):e2300034. PubMed ID: 37189215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
    Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
    Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients.
    Grimaldi A; Panariello F; Annunziata P; Giuliano T; Daniele M; Pierri B; Colantuono C; Salvi M; Bouché V; Manfredi A; Cuomo MC; Di Concilio D; Tiberio C; Fiorenza M; Portella G; Cimmino I; Sorrentino A; Fusco G; Granata MR; Cerino P; Limone A; Atripaldi L; Ballabio A; Cacchiarelli D
    Genome Med; 2022 Aug; 14(1):90. PubMed ID: 35962405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
    Hosoki K; Chakraborty A; Sur S
    J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intranasal ASO therapeutic targeting SARS-CoV-2.
    Zhu C; Lee JY; Woo JZ; Xu L; Nguyenla X; Yamashiro LH; Ji F; Biering SB; Van Dis E; Gonzalez F; Fox D; Wehri E; Rustagi A; Pinsky BA; Schaletzky J; Blish CA; Chiu C; Harris E; Sadreyev RI; Stanley S; Kauppinen S; Rouskin S; Näär AM
    Nat Commun; 2022 Aug; 13(1):4503. PubMed ID: 35922434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell lymphoma-2 family proteins-activated proteases as potential therapeutic targets for influenza A virus and severe acute respiratory syndrome coronavirus-2: Killing two birds with one stone?
    Soni S; Mebratu YA
    Rev Med Virol; 2023 Mar; 33(2):e2411. PubMed ID: 36451345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.
    Chen P; Wu M; He Y; Jiang B; He ML
    Signal Transduct Target Ther; 2023 Jun; 8(1):237. PubMed ID: 37286535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target.
    Abu-Farha M; Thanaraj TA; Qaddoumi MG; Hashem A; Abubaker J; Al-Mulla F
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological aspects of SARS-CoV-2 infection: lipoproteins and exosomes as Trojan horses.
    Lam SM; Huang X; Shui G
    Trends Endocrinol Metab; 2022 Aug; 33(8):554-568. PubMed ID: 35613979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods.
    Yu S; Li X; Xin Z; Sun L; Shi J
    Front Immunol; 2022; 13():923387. PubMed ID: 36203586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19: A Multidisciplinary Review.
    Chams N; Chams S; Badran R; Shams A; Araji A; Raad M; Mukhopadhyay S; Stroberg E; Duval EJ; Barton LM; Hajj Hussein I
    Front Public Health; 2020; 8():383. PubMed ID: 32850602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.